NCT05584787View on ClinicalTrials.gov

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

March 30, 2024

Conditions
Prostate Cancer
Interventions
PROCEDURE

Soractelite Echolaser Transperineal focal laser ablation

US/MRI fusion laser ablation of low- and intermediate risk prostate cancer

Trial Locations (1)

00175

RECRUITING

San Carlo di Nancy Hospital, Roma

All Listed Sponsors
collaborator

Elesta S.R.L.

INDUSTRY

lead

San Carlo di Nancy Hospital

OTHER